Recap of the 8th Munich Metabolomics Symposium, November 12th, 2021
The 8th Munich Metabolomics Symposium
read more
All posts to the category
Recap of the 8th Munich Metabolomics Symposium, November 12th, 2021
A multi-OMICS approach identified metabolic signatures related to fatty acid oxidation in bladder cancer progression.
Cancer in comparison to chemotherapy cause distinct metabolic perturbations, which both lead to the development and progression of cachexia characterized by extreme weight loss and muscle wasting.
Acylcarnitine profiles of melanoma xenografts in mice could be a step towards a new treatment.
The changes in circulating metabolites induced by a multi-AGC kinase inhibitor in mice and patients may contribute to better understand its mechanism of action.